Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ME Therapeutics Holdings, Inc. (TSE:METX)
CNQX:METX
RESEARCH TOOLSreports
ME Therapeutics Holdings, Inc. (METX) Stock Price & Analysis
6 Followers
METX Stock Chart & Stats
Day’s RangeC$3.66 - C$3.66
52-Week Range― - ―
Previous CloseC$3.61
Volume2.15K
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Mar 23, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ME Therapeutics Holdings, Inc. News
PremiumCompany Announcements
ME Therapeutics Celebrates CSE Bell-Ringing EventPremiumCompany Announcements
ME Therapeutics Awards Stock OptionsPremiumCompany Announcements
ME Therapeutics Enhances Investor OutreachPremiumCompany Announcements
ME Therapeutics Secures $1.5M in Private PlacementOptions Prices
Currently, No data available
---
Ownership Overview
18.00% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
82.00% Public Companies and
Individual Investors
METX FAQ
What was ME Therapeutics Holdings, Inc.’s price range in the past 12 months?
Currently, no data Available
What is ME Therapeutics Holdings, Inc.’s market cap?
Currently, no data Available
When is ME Therapeutics Holdings, Inc.’s upcoming earnings report date?
ME Therapeutics Holdings, Inc.’s upcoming earnings report date is Mar 23, 2024 which is 48 days ago.
How were ME Therapeutics Holdings, Inc.’s earnings last quarter?
ME Therapeutics Holdings, Inc. released its earnings results on Jan 24, 2024. The company reported -C$0.015 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.015.
Is ME Therapeutics Holdings, Inc. overvalued?
According to Wall Street analysts ME Therapeutics Holdings, Inc.’s price is currently Overvalued.
Does ME Therapeutics Holdings, Inc. pay dividends?
ME Therapeutics Holdings, Inc. does not currently pay dividends.
What is ME Therapeutics Holdings, Inc.’s EPS estimate?
ME Therapeutics Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ME Therapeutics Holdings, Inc. have?
Currently, no data Available
What happened to ME Therapeutics Holdings, Inc.’s price movement after its last earnings report?
ME Therapeutics Holdings, Inc. reported an EPS of -C$0.015 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -22.308%.
Which hedge fund is a major shareholder of ME Therapeutics Holdings, Inc.?
Currently, no hedge funds are holding shares in TSE:METX
---
ME Therapeutics Holdings, Inc. Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2453.92%
Trailing 12-Months
Company Description
ME Therapeutics Holdings, Inc.
ME Therapeutics is a pre-clinical biopharmaceutical company dedicated to the discovery and development of novel cancer immunotherapies. Using our combined expertise in tumour immunology, T cell biology and myeloid cell development, we are developing biological and small molecule drugs to target novel pathways involved in cancer-induced immune suppression. Our therapies have the potential to work on their own and in combination with other cancer immunotherapies across several cancer types.
---
Technical Analysis
---